EX-10.18-K·CIK 1894525·0001213900-26-092680

ASSIGNMENT AND TRANSFER AGREEMENT OF CERTAIN APITOX RIGHTS, DATED AUGUST 19, 2026, BY AND BETWEEN APIMEDS PHARMACEUTICALS US, INC. AND FREET INC

View original filing on SEC EDGAR → · seen Aug 21, 2026, 17:12 EDT

Export to Cicero →

FILING DETAILS

Filer: Apimeds Pharmaceuticals US, Inc.
Period of report: Aug 19, 2026
Filed: Aug 21, 2026
SEC file no.: 001-42545
State of inc.: DE
SIC: 2834
Location: MATAWAN, NJ

Entry into a Material Definitive Agreement
Financial Statements and Exhibits

Exhibit 10.1

Docusign Envelope ID: BDB7F9F5-66FB-8362-8158-B0DC41C63A0A

Docusign Envelope ID: BDB7F9F5-66FB-8362-8158-B0DC41C63A0A

Docusign Envelope ID: BDB7F9F5-66FB-8362-8158-B0DC41C63A0A

Docusign Envelope ID: BDB7F9F5-66FB-8362-8158-B0DC41C63A0A

Docusign Envelope ID: BDB7F9F5-66FB-8362-8158-B0DC41C63A0A

Docusign Envelope ID: BDB7F9F5-66FB-8362-8158-B0DC41C63A0A

Docusign Envelope ID: BDB7F9F5-66FB-8362-8158-B0DC41C63A0A

Docusign Envelope ID: BDB7F9F5-66FB-8362-8158-B0DC41C63A0A

Docusign Envelope ID: BDB7F9F5-66FB-8362-8158-B0DC41C63A0A

Docusign Envelope ID: BDB7F9F5-66FB-8362-8158-B0DC41C63A0A

Docusign Envelope ID: BDB7F9F5-66FB-8362-8158-B0DC41C63A0A

Docusign Envelope ID: BDB7F9F5-66FB-8362-8158-B0DC41C63A0A

← Back to all agreements